Page last updated: 2024-11-05

ticlopidine and Antiphospholipid Syndrome

ticlopidine has been researched along with Antiphospholipid Syndrome in 4 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).

Research Excerpts

ExcerptRelevanceReference
"Stasis ulcers are commonly the result of chronic venous insufficiency."5.31Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001)
"Intrahepatic hemorrhage is a very rare complication of warfarin, and our patient experienced intrahepatic and subgaleal hemorrhage although she did not have any risk factors for bleeding or instability of the international normalized ratio control."1.39Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy. ( Baek, YH; Cho, DS; Chung, WT; Han, SY; Kang, SH; Lee, SW; Park, IC, 2013)
"Stasis ulcers are commonly the result of chronic venous insufficiency."1.31Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, IC1
Baek, YH1
Han, SY1
Lee, SW2
Chung, WT1
Kang, SH1
Cho, DS1
Chemnitz, J1
Söhngen, D1
Schulz, A1
Diehl, V1
Scheid, C1
Bick, RL1
Scott, RG1
Undas, A1
Bazan-Socha, S1
Swadzba, J1
Musial, J1

Other Studies

4 other studies available for ticlopidine and Antiphospholipid Syndrome

ArticleYear
Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy.
    World journal of gastroenterology, 2013, Oct-14, Volume: 19, Issue:38

    Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Chemical and Drug Induced Liver Injury; Clopi

2013
Fatal toxic bone marrow failure associated with clopidogrel.
    European journal of haematology, 2003, Volume: 71, Issue:6

    Topics: Adult; Antiphospholipid Syndrome; Bone Marrow Diseases; Clopidogrel; Fatal Outcome; Female; Humans;

2003
Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Clopidogrel; Dalteparin;

2001
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:1

    Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Autoantibodies; Factor V; Female; Humans; Is

2002